These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10257313)

  • 1. Excess marks the spot: the FDA blows the whistle on abuses in new-drug ads.
    Time; 1982 Sep; 120(13):83. PubMed ID: 10257313
    [No Abstract]   [Full Text] [Related]  

  • 2. Advertisements. FDA orders Abbott to change misleading ads for Norvir.
    AIDS Policy Law; 2004 Jul; 19(12):9. PubMed ID: 15282864
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug risks and free speech--can Congress ban consumer drug ads?
    Shuchman M
    N Engl J Med; 2007 May; 356(22):2236-9. PubMed ID: 17476002
    [No Abstract]   [Full Text] [Related]  

  • 4. US aims to tighten rules on direct-to-consumer drug ads.
    Vastag B
    Nat Biotechnol; 2007 Mar; 25(3):267. PubMed ID: 17344868
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA tightens rules on advertising.
    Josefson D
    BMJ; 1997 Aug; 315(7106):447. PubMed ID: 9284658
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmaceuticals and medical devices: FDA oversight. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2008 Jan; ():1-18. PubMed ID: 18345557
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmaceuticals and medical devices: FDA oversight.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2009 Jan; ():1-28. PubMed ID: 19297718
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA finalizing policy statement on industry-supported activities.
    Am J Hosp Pharm; 1993 Mar; 50(3):391. PubMed ID: 8442443
    [No Abstract]   [Full Text] [Related]  

  • 9. FDA considers tightening regulations for direct-to-consumer advertising.
    Vastag B
    J Natl Cancer Inst; 2005 Dec; 97(24):1806-7. PubMed ID: 16368941
    [No Abstract]   [Full Text] [Related]  

  • 10. Free rein for drug ads? A slowdown in FDA review has left consumers more vulnerable to misleading messages.
    Consum Rep; 2003 Feb; 68(2):33-7. PubMed ID: 12516586
    [No Abstract]   [Full Text] [Related]  

  • 11. Ensuring that consumers receive appropriate information from drug ads: what is the FDA's role?
    Waxman HA
    Health Aff (Millwood); 2004; Suppl Web Exclusives():W4-256-8. PubMed ID: 15452002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug advertising. GAO spurs advocates to urge FDA fast-track oversight of drug ads.
    AIDS Policy Law; 2006 Dec; 22(1):1, 4. PubMed ID: 17278241
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug firms back-pedal on direct advertising.
    Nature; 2005 Aug; 436(7053):910-1. PubMed ID: 16107811
    [No Abstract]   [Full Text] [Related]  

  • 14. The great debate over drug ads.
    Atkinson H
    Health News; 1999 Jun; 5(8):4. PubMed ID: 10397029
    [No Abstract]   [Full Text] [Related]  

  • 15. The promise and peril of direct-to-consumer prescription drug promotion on the Internet.
    Hall TS
    DePaul J Health Care Law; 2003; 7(1):1-41. PubMed ID: 15468476
    [No Abstract]   [Full Text] [Related]  

  • 16. It's only skin deep: FDA regulation of skin care cosmetics claims.
    Liang BA; Hartman KM
    Cornell J Law Public Policy; 1999; 8(2):249-80. PubMed ID: 11010667
    [No Abstract]   [Full Text] [Related]  

  • 17. Food and Drug Administration surveillance of dermatology-related and nondermatology-related prescription drug advertising in the USA, 2000-2003.
    Cowden AL; Katz KA
    Br J Dermatol; 2006 May; 154(5):950-8. PubMed ID: 16634900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dealing with drug advertising. The FDA can't always enforce the rules on misleading ads.
    Atkinson HG
    Health News; 2003 Feb; 9(2):5. PubMed ID: 12632541
    [No Abstract]   [Full Text] [Related]  

  • 19. FDA questions San Francisco HIV/AIDS drug advertisements.
    AIDS Policy Law; 2001 May; 16(9):1, 6. PubMed ID: 11668819
    [No Abstract]   [Full Text] [Related]  

  • 20. Perspectives. New twist on guideline dissemination stirs professional debate, gets slap from FDA.
    Newman L
    Med Health; 1999 Feb; 53(8):suppl 1-4. PubMed ID: 10345551
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.